<DOC>
	<DOCNO>NCT00122018</DOCNO>
	<brief_summary>Patients abnormal kidney function increase risk complication follow heart surgery , include worsen kidney function possibly require dialysis , prolong stay critical care unit hospital , increase risk death . Prior attempt kidney protection heart surgery patient mixed result . Two medicine , fenoldopam N-acetylcysteine , show protect kidney function circumstance cause kidney stress . The purpose study determine whether medication help maintain function diseased kidney heart surgery .</brief_summary>
	<brief_title>An Investigation N-acetylcysteine Fenoldopam Renal Protection Agents Cardiac Surgery</brief_title>
	<detailed_description>This randomize , double-blinded , placebo-controlled trial evaluate fenoldopam N-acetylcysteine ( NAC ) individually , together , renal protective agent patient renal insufficiency undergo heart surgery . Subjects chronic renal insufficiency creatinine clearance ( CrCl ) &lt; /= 40cc/min pre-operative dialysis , receive : NAC 600 mg mouth ( po ) twice day ( bid ) placebo start 24 hour pre-operative continue day surgery ; and/or fenoldopam 0.1 mcg/kg/min intravenous ( IV ) saline placebo anesthetic induction continue 48 hour . Outcome data include : nadir , post-operative day 3 post-operative day 14 CrCl , time CrCl nadir , length Intensive Care Unit ( ICU ) stay , length post-operative hospital stay , hospital cost , mortality , need hemodialysis . Intraoperative post-operative pressor use monitor . The enrollment include 80 patient ( 20 group ) .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<mesh_term>Fenoldopam</mesh_term>
	<criteria>Chronic creatinine clearance &lt; /= 40cc/h Preoperative cardiac surgery Preoperative ongoing dialysis Nausea vomit Uncontrolled glaucoma Allergy metabisulfite Enrollment another clinical study within 30 day Pregnancy Acute renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Kidney failure</keyword>
	<keyword>Cardiac Surgery</keyword>
	<keyword>Fenoldopam</keyword>
	<keyword>N-acetylcysteine</keyword>
</DOC>